Dentsply Sirona Inc. (XRAY) director gets RSU dividend shares credited

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Clyde Hosein reported an automatic stock acquisition tied to his existing equity awards. On 01/09/2026, he received 355.0455 shares of common stock at a price of $0, described as dividends on restricted stock units (RSUs) that are paid in the form of additional RSUs.

The footnote explains that these dividend RSUs carry the same vesting terms as the original RSU awards and will vest at the same time as the underlying grants, with each RSU converting into one share of common stock. Following this transaction, Hosein directly beneficially owned 41,252.522 shares of DENTSPLY SIRONA common stock.

Insider Trade Summary

Net Buyer: 355.0455 shares

Net Buy 1 txn

Insider HOSEIN CLYDE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	355.0455	$0.00	$0.00

Holdings After Transaction: Common Stock — 41,252.522 shares (Direct)

Footnotes (1)

1. F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Clyde Hosein?

DENTSPLY SIRONA Inc. director Clyde Hosein reported an acquisition of 355.0455 shares of common stock on 01/09/2026, shown as a stock transaction code "A" for acquisition at a price of $0 per share.

Why did Clyde Hosein receive 355.0455 DENTSPLY SIRONA shares?

According to the footnote, the 355.0455 shares represent dividends on restricted stock units (RSUs) awarded to Hosein. These dividends are paid in the form of additional RSUs that are subject to the same vesting terms as the underlying RSU awards.

How many DENTSPLY SIRONA shares does Clyde Hosein own after this Form 4 transaction?

After the reported RSU dividend transaction, Clyde Hosein beneficially owns 41,252.522 shares of DENTSPLY SIRONA common stock, held in direct ownership form.

Was this DENTSPLY SIRONA (XRAY) Form 4 transaction an open-market purchase or sale?

No open-market trade is indicated. The Form 4 shows a transaction code "A" at a price of $0 per share, with the footnote clarifying it as dividends on RSUs credited in the form of additional RSUs that later convert into common stock.

How do the RSU dividend shares reported by Clyde Hosein vest at DENTSPLY SIRONA?

The footnote states that the RSU dividend shares are subject to the same vesting terms as the underlying RSU awards, and that the dividends vest simultaneously with the related RSUs. Each RSU converts into one share of common stock upon vesting.

What is Clyde Hosein’s role at DENTSPLY SIRONA Inc.?

The filing identifies HOSEIN CLYDE as a Director of DENTSPLY SIRONA Inc. and confirms that the Form 4 is filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/13/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOSEIN CLYDE

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		355.0455(1)	A	$0	41,252.522	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Clyde Hosein	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.